Nomura Holdings
ONCE

Nomura Holdings’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Nomura Holdings’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-5,000
Closed -$512K – 1494
2019
Q2 		$512K Buy
+5,000
New +$540K ﹤0.01% 943

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Nomura Holdings's ONCE Position: Q3 2019 in Review

Nomura Holdings sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q3 2019, closing a stake of 5,000 shares — an estimated $512K sold.

Nomura Holdings first reported a position in ONCE in Q2 2019 and held it in 1 quarter. The position peaked at $512K in Q2 2019. 184 funds tracked by Wall St. Rank hold ONCE as of Q3 2019.

  • Nomura Holdings reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Nomura Holdings sold 5,000 Spark Therapeutics, Inc. Common Stock shares in Q3 2019, an estimated $512K.
  • Nomura Holdings first reported a position in Spark Therapeutics, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Nomura Holdings's Spark Therapeutics, Inc. Common Stock position peaked at $512K in Q2 2019.
  • 184 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q3 2019.

Based on Nomura Holdings's 13F filing for Q3 2019, filed 14 Nov 2019.